Florence Ranchon
YOU?
Author Swipe
View article: The French Experience of Pharmacists and CAR T‐Cells: A Study of the French Society of Oncology Pharmacy (SFPO)
The French Experience of Pharmacists and CAR T‐Cells: A Study of the French Society of Oncology Pharmacy (SFPO) Open
The aim of this study was to describe the initial 3‐year experience in vein‐to‐vein time for axi‐cel therapy and the role of pharmacists in the first recruiting French centers. Retrospective observational data were collected for vein‐to‐ve…
View article: Fiche réflexe : prise en charge du patient cancéreux
Fiche réflexe : prise en charge du patient cancéreux Open
View article: Randomised controlled trial to assess the impact of hospital–community pharmaceutical care on drug-related problems in oncology practice for at-risk outpatients treated with oral anticancer drugs—a French Society for Oncology Pharmacy (SFPO) study: DROP-SFPO study protocol
Randomised controlled trial to assess the impact of hospital–community pharmaceutical care on drug-related problems in oncology practice for at-risk outpatients treated with oral anticancer drugs—a French Society for Oncology Pharmacy (SFPO) study: DROP-SFPO study protocol Open
Introduction Drug-related problems (DRPs) associated with oral anticancer drugs are frequent and require a new healthcare organisation to manage them on an outpatient basis. The aim of this article is to present the study protocol of the D…
View article: Oncoral Follow-Up for Outpatients Treated with Oral Anticancer Drugs Assessed by Relative Dose Intensity
Oncoral Follow-Up for Outpatients Treated with Oral Anticancer Drugs Assessed by Relative Dose Intensity Open
Objectives: The multidisciplinary city-hospital Oncoral follow-up of cancer outpatients has been set up to ensure the safety of oral anticancer drugs (OADs). The aim of this study was to assess Oncoral by Relative Dose Intensity (RDI) in p…
View article: Corrigendum to “Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients – A retrospective analysis” [Eur J Surg Oncol 50/2 (2024) 107955]
Corrigendum to “Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients – A retrospective analysis” [Eur J Surg Oncol 50/2 (2024) 107955] Open
View article: Simplification de la gestion des accès dérogatoires en oncologie grâce à ONCOACCESS, le nouvel outil numérique de la SFPO
Simplification de la gestion des accès dérogatoires en oncologie grâce à ONCOACCESS, le nouvel outil numérique de la SFPO Open
View article: Pharmacy Education and Clinical Pharmacy Training in France
Pharmacy Education and Clinical Pharmacy Training in France Open
Clinical pharmacy education varies widely between European countries, and several major changes have taken place in France. This review aims to describe the current state of pharmacy education in France, focusing on clinical pharmacy. Rese…
View article: Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program
Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program Open
Background Healthcare professionals are faced with the new challenges of preventing and managing drug-related problems (DRPs) with oral anticancer therapy (OAT): side-effects, drug–drug interactions (DDIs), non-adherence, or medication err…
View article: Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study
Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study Open
Introduction The development of oral anticancer agents (OAA) has profoundly changed cancer care, leading patients to manage their chemotherapy treatment on an outpatient basis. The prevention of iatrogenic effects of OAA remains a major co…
View article: Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients – A retrospective analysis
Eliminating the need for preoperative intravenous hyperhydration: Sodium thiosulfate as nephrotoxicity prevention in HIPEC-treated patients – A retrospective analysis Open
View article: Clinical impact and cost‐saving analysis of a comprehensive pharmaceutical care intervention in older patients with cancer
Clinical impact and cost‐saving analysis of a comprehensive pharmaceutical care intervention in older patients with cancer Open
Background Hospital admission and discharge are at high risk of drug‐related problems (DRPs) in older patients with cancer. This study aimed to assess the clinical and economic impact of a comprehensive pharmaceutical care intervention (RE…
View article: Cancer outpatients during the COVID-19 pandemic: what Oncoral has to teach us about medical drug use and the perception of telemedicine
Cancer outpatients during the COVID-19 pandemic: what Oncoral has to teach us about medical drug use and the perception of telemedicine Open
View article: Development of Indirect Health Data Linkage on Health Product Use and Care Trajectories in France: Systematic Review
Development of Indirect Health Data Linkage on Health Product Use and Care Trajectories in France: Systematic Review Open
Background European national disparities in the integration of data linkage (ie, being able to match patient data between databases) into routine public health activities were recently highlighted. In France, the claims database covers alm…
View article: Pandémie à SARS-COV-2 : implication du pharmacien hospitalier dans la sécurisation de la prise en charge des patients
Pandémie à SARS-COV-2 : implication du pharmacien hospitalier dans la sécurisation de la prise en charge des patients Open
View article: Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review
Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review Open
View article: Ovarian cancer in the older patient: where are we now? What to do next?
Ovarian cancer in the older patient: where are we now? What to do next? Open
In recent years, major advances have been made toward the individualization of epithelial ovarian cancer care, leading to an overall improvement of patient outcomes. However, real-life data indicate that the oldest populations do not benef…
View article: 2022-RA-1063-ESGO There is no benefit for preoperative hyperhydration before cytoreductive surgery and hyperthermic intrapertioneal chemotherapy (HIPEC) with cisplatin when combined with sodium thiosulfate
2022-RA-1063-ESGO There is no benefit for preoperative hyperhydration before cytoreductive surgery and hyperthermic intrapertioneal chemotherapy (HIPEC) with cisplatin when combined with sodium thiosulfate Open
View article: Development of Indirect Health Data Linkage on Health Product Use and Care Trajectories in France: Systematic Review (Preprint)
Development of Indirect Health Data Linkage on Health Product Use and Care Trajectories in France: Systematic Review (Preprint) Open
BACKGROUND European national disparities in the integration of data linkage (ie, being able to match patient data between databases) into routine public health activities were recently highlighted. In France, the claims database covers al…
View article: Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program Open
Background In previous studies, patient-reported outcomes (PROs) have been shown to improve survival in cancer patients. The aim of the present study was to assess symptoms potentially related to adverse events experienced by cancer outpat…
View article: How a Patient Personalised Clinical Pharmacy Programme Can Secure Therapeutic Care in an Orthogeriatric Care Pathway (5P Project)?
How a Patient Personalised Clinical Pharmacy Programme Can Secure Therapeutic Care in an Orthogeriatric Care Pathway (5P Project)? Open
The 5P project secured the orthogeriatric care pathway by detecting a great number of potential ME, including PI mostly considered as having a significant clinical impact.
View article: Development of clinical pharmacy programs integrated into patient care pathways using adverse event risks
Development of clinical pharmacy programs integrated into patient care pathways using adverse event risks Open
View article: Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study Open
View article: Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases
Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases Open
View article: Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects
Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects Open
Long-term multiple myeloma therapy by immunomodulatory drugs (IMiDs) raises the question of management of adverse effects. The aim of this study is to assess the impact of an educational session for patients on the acquisition of knowledge…
View article: Commercial <scp>anti‐CD19 CAR</scp> T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
Commercial <span>anti‐CD19 CAR</span> T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center Open
Two autologous anti‐CD19 chimeric antigen receptors (CAR) T cells (axicabtagene ciloleucel [axi‐cel] and tisagenlecleucel [tisa‐cel]) are commercially approved in Europe for relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL). …
View article: Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines) Open
View article: Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin
Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin Open
ST appears to be an effective drug for the prevention of the renal toxicity of CDDP used for HIPEC and should be used for all such procedures.
View article: Physico-Chemical Stability of Sodium Thiosulfate Infusion Solutions in Polyolefin Bags at Room Temperature over a Period of 24 Hours
Physico-Chemical Stability of Sodium Thiosulfate Infusion Solutions in Polyolefin Bags at Room Temperature over a Period of 24 Hours Open
Background Many publications described sodium thiosulfate used to prevent the renal toxicity induced by cisplatin hyperthermic intraperitoneal chemotherapy. After around 60 or 90 minutes of hyperthermic chemotherapy, cisplatin was drained …
View article: SIMulation of Medication Error induced by Clinical Trial drug labeling: the SIMME-CT study
SIMulation of Medication Error induced by Clinical Trial drug labeling: the SIMME-CT study Open
SIMME-CT is the first simulation-based learning tool to focus on investigational drug labels as a risk factor for medication error. SIMME-CT was also used as a training tool for staff involved in clinical research, to develop medication er…
View article: Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods Open
These encouraging primary results suggest that further studies should be undertaken and that educational programs tailored to patient profiles should be evaluated to enhance adherence for those who need it and to empower all patients to ma…